Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic User Fees Have Four-Month Negotiating Window As Differences Narrow

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA calculates it that needs to reach an agreement with industry by June in order to have a proposal ready for Congress by early 2012.
Advertisement

Related Content

ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
Generic User Fee Negotiators Struggling To Meet June Deadline
GPhA Seeks New Driver As Outgoing VP Johnston Continues To Ford Across User Fee Stream
FDA-EMA-TGA Joint Inspection Program To Be Permanent; Other Collaborations Expand
FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
Hamburg Says Generic Drug Reviews Would Slow In Wake Of GOP-Backed Budget Cuts
Generic User Fee Negotiations Begin In Ernest On Feb. 28 With Four Seats At The Table
Generic User Fees: FDA Reaches Out To More Trade Groups; Plan Could Mix Inspection and Application Fees
GDUFA Timetable Unclear, But Negotiations Will Begin With Lots Of Agreement - Except For Mylan
GDUFA Timetable Unclear, But Negotiations Will Begin With Lots Of Agreement - Except For Mylan

Topics

Advertisement
UsernamePublicRestriction

Register

PS071873

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel